Barclays Raises Oracle (NYSE:ORCL) Price Target to $281.00

Key Points

• Barclays has raised Oracle's price target from $221.00 to $281.00, indicating a potential upside of 20.67% from its previous close.
• Oracle's stock has shown strong performance with a price increase of 4.4%, and it reported revenue of $15.90 billion for the last quarter, surpassing analyst expectations.
• Currently, Oracle has a consensus rating of "Moderate Buy" with three analysts rating it as a Strong Buy and a price target average of $229.18.

Oracle (NYSE:ORCL - Get Free Report) had its price target boosted by analysts at Barclays from $221.00 to $281.00 in a report released on Monday, Marketbeat Ratings reports. The firm presently has an "overweight" rating on the enterprise software provider's stock. Barclays's target price points to a potential downside of 14.43% from the company's previous close.

ORCL has been the topic of a number of other reports. Guggenheim upped their price objective on Oracle from $220.00 to $250.00 and gave the company a "buy" rating in a research report on Wednesday, June 18th. Evercore ISI boosted their target price on Oracle from $215.00 to $270.00 and gave the company an "outperform" rating in a research report on Monday, July 14th. Roth Capital restated a "hold" rating on shares of Oracle in a research report on Wednesday, June 18th. DA Davidson lifted their price objective on shares of Oracle from $140.00 to $170.00 and gave the stock a "neutral" rating in a research note on Thursday, June 12th. Finally, Citigroup raised shares of Oracle from a "hold" rating to a "strong-buy" rating in a research note on Friday, July 18th. Two research analysts have rated the stock with a Strong Buy rating, twenty-five have given a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, Oracle presently has an average rating of "Moderate Buy" and a consensus price target of $291.23.

Oracle Price Performance

Shares of NYSE:ORCL traded up $86.89 on Monday, reaching $328.40. The company's stock had a trading volume of 131,092,718 shares, compared to its average volume of 12,084,960. The company has a 50-day simple moving average of $240.23 and a 200 day simple moving average of $187.60. Oracle has a 52-week low of $118.86 and a 52-week high of $345.72. The company has a debt-to-equity ratio of 4.07, a quick ratio of 0.75 and a current ratio of 0.75. The company has a market cap of $922.41 billion, a P/E ratio of 49.49, a PEG ratio of 3.61 and a beta of 1.46.

Oracle (NYSE:ORCL - Get Free Report) last announced its earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.06. The firm had revenue of $15.90 billion for the quarter, compared to analysts' expectations of $15.58 billion. Oracle had a net margin of 21.08% and a return on equity of 80.42%. The business's revenue was up 11.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.63 EPS. As a group, equities research analysts anticipate that Oracle will post 5 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Naomi O. Seligman sold 3,303 shares of the stock in a transaction that occurred on Wednesday, July 16th. The stock was sold at an average price of $233.32, for a total value of $770,655.96. Following the transaction, the director owned 31,447 shares of the company's stock, valued at $7,337,214.04. This represents a 9.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Michael D. Sicilia sold 15,880 shares of the firm's stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $254.48, for a total value of $4,041,142.40. Following the transaction, the insider owned 99,212 shares in the company, valued at $25,247,469.76. The trade was a 13.80% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 444,183 shares of company stock worth $86,521,198. 42.20% of the stock is owned by company insiders.

Hedge Funds Weigh In On Oracle

Several institutional investors have recently made changes to their positions in ORCL. Harel Insurance Investments & Financial Services Ltd. raised its holdings in Oracle by 71.6% in the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 257,378 shares of the enterprise software provider's stock worth $35,984,000 after purchasing an additional 107,404 shares in the last quarter. Lockheed Martin Investment Management Co. boosted its position in Oracle by 4.3% during the first quarter. Lockheed Martin Investment Management Co. now owns 51,350 shares of the enterprise software provider's stock worth $7,179,000 after purchasing an additional 2,110 shares in the last quarter. Nuveen LLC purchased a new stake in Oracle in the 1st quarter worth $732,692,000. Rockland Trust Co. raised its position in shares of Oracle by 4.8% during the 1st quarter. Rockland Trust Co. now owns 10,165 shares of the enterprise software provider's stock worth $1,421,000 after purchasing an additional 467 shares during the last quarter. Finally, Calamos Advisors LLC lifted its position in shares of Oracle by 1.5% in the first quarter. Calamos Advisors LLC now owns 711,290 shares of the enterprise software provider's stock valued at $99,445,000 after acquiring an additional 10,426 shares in the last quarter. Hedge funds and other institutional investors own 42.44% of the company's stock.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.